Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
69.59
+1.65 (2.43%)
Feb 3, 2026, 3:04 PM CST

SHE:300573 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
2,3881,9241,4401,2271,024683.22
Other Revenue
19.4919.4927.8623.23.65.46
2,4081,9431,4681,2501,028688.68
Revenue Growth (YoY)
33.62%32.42%17.42%21.59%49.26%26.96%
Cost of Revenue
468.86424.53340.36270.08229.01187.87
Gross Profit
1,9391,5191,127979.78798.91500.81
Selling, General & Admin
913.07875.78689.8595.39456.54321.34
Research & Development
236.3220.66167.3145.6188.4563.19
Other Operating Expenses
16.4410.687.166.6613.83.14
Operating Expenses
1,1711,110867.29748.58558.6388.71
Operating Income
768.32408.42259.93231.2240.31112.1
Interest Expense
-5.45-5.71-1.44-0.94-5.99-5.94
Interest & Investment Income
2.765.667.919.933.980.22
Currency Exchange Gain (Loss)
-0.11-0.110.2-0.09-0.13-0.02
Other Non Operating Income (Expenses)
10.91-2.11-1.15-19.31-1.05-3.74
EBT Excluding Unusual Items
776.43406.15265.45220.79237.12102.62
Gain (Loss) on Sale of Investments
--0.02----
Gain (Loss) on Sale of Assets
-1.01-0.98-0.040.425.16-0.08
Asset Writedown
-18.72-14.05--0-0-
Other Unusual Items
-10.763.94-0.4212.511.26-
Pretax Income
745.94395.03264.99233.72243.54102.54
Income Tax Expense
99.7456.9724.9622.0334.439.08
Earnings From Continuing Operations
646.21338.06240.04211.68209.1193.46
Minority Interest in Earnings
-----14.41-5.48
Net Income
646.21338.06240.04211.68194.787.98
Net Income to Common
646.21338.06240.04211.68194.787.98
Net Income Growth
85.44%40.84%13.39%8.72%121.31%145.11%
Shares Outstanding (Basic)
245244244241224221
Shares Outstanding (Diluted)
246245244241224225
Shares Change (YoY)
0.66%0.70%0.96%7.45%-0.30%2.88%
EPS (Basic)
2.641.390.990.880.870.40
EPS (Diluted)
2.631.380.990.880.870.39
EPS Growth
84.22%39.86%12.32%1.19%120.40%139.95%
Free Cash Flow
409.46218.2755.61-12.96211.914.01
Free Cash Flow Per Share
1.660.890.23-0.050.940.06
Dividend Per Share
1.4141.0711.8880.5470.2370.091
Dividend Growth
-24.79%-43.25%245.37%130.73%160.04%99.78%
Gross Margin
80.53%78.16%76.81%78.39%77.72%72.72%
Operating Margin
31.91%21.02%17.71%18.50%23.38%16.28%
Profit Margin
26.84%17.39%16.36%16.94%18.94%12.78%
Free Cash Flow Margin
17.00%11.23%3.79%-1.04%20.61%2.03%
EBITDA
868.01499.83340.3297.23297.55157.61
EBITDA Margin
36.05%25.72%23.19%23.78%28.95%22.88%
D&A For EBITDA
99.6991.4280.3866.0357.2445.51
EBIT
768.32408.42259.93231.2240.31112.1
EBIT Margin
31.91%21.02%17.71%18.50%23.38%16.28%
Effective Tax Rate
13.37%14.42%9.42%9.43%14.14%8.86%
Revenue as Reported
2,4081,9431,4681,2501,028688.68
Advertising Expenses
-42.5213.81135.226.89
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.